5522-39-4

Basic information

• Product Name: difluanazine
• Synonyms: difluanazine;N-[2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]ethyl]aniline;1-(2-Anilinoethyl)-4-[4,4-bis(p-fluorophenyl)butyl]piperazine;Difluanine;2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]ethyl-phenyl-amine;Difloxacin hydrochlorid;N-(2-{4-[4,4-Bis(4-fluorophenyl)butyl]-1-piperazinyl}ethyl)aniline
• CAS NO: 5522-39-4
• Molecular Formula: C28H33F2N3
• Molecular Weight: 449.58
• Mol File: 5522-39-4.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 581.1 °C at 760 mmHg
• Flash Point: 305.3 °C
• Appearance: /
• Density: 1.142 g/cm³
• Vapor Pressure: 1.7E-13mmHg at 25°C
• Refractive Index: 1.583
• CAS DataBase Reference: difluanazine(CAS DataBase Reference)
• NIST Chemistry Reference: difluanazine(5522-39-4)
• EPA Substance Registry System: difluanazine(5522-39-4)

Safety Data

• Hazardous Substances Data: 5522-39-4(Hazardous Substances Data)

Usage

Description

Difluanazine is a pharmaceutical compound that belongs to the phenothiazine class of drugs. It is characterized by its stimulant properties, particularly as a central nervous system stimulant. Difluanazine has been found to be effective in various applications due to its unique chemical structure and pharmacological properties.

Uses

1. Central Nervous System Stimulant:
Difluanazine is used as a central nervous system stimulant for its ability to increase alertness, attention, and overall cognitive function. This application is particularly useful in treating conditions that involve fatigue, lack of focus, or cognitive impairment.
2. Reversal of Multidrug Resistance:
In the pharmaceutical industry, difluanazine is used for the reversal of multidrug resistance caused by phenothiazines and structurally related compounds. This application is crucial in overcoming resistance to certain medications, allowing for more effective treatment plans and improved patient outcomes.
3. Anticancer Applications (if applicable):
If difluanazine has been found to have anticancer properties, it could be used as an anticancer agent, targeting specific types of cancer and modulating various oncological signaling pathways. This application would be particularly relevant in the field of oncology and cancer research.
4. Drug Delivery Systems (if applicable):
Similar to gallotannin, if difluanazine faces limitations in its current form, novel drug delivery systems could be developed to enhance its applications and efficacy. This could involve the use of organic and metallic nanoparticles as carriers for difluanazine delivery, aiming to improve its bioavailability and therapeutic outcomes in various medical applications.

InChI:InChI=1/C28H33F2N3/c29-25-12-8-23(9-13-25)28(24-10-14-26(30)15-11-24)7-4-17-32-19-21-33(22-20-32)18-16-31-27-5-2-1-3-6-27/h1-3,5-6,8-15,28,31H,4,7,16-22H2